Want to see AU:EPN full AI Analyst Report?
EPN Stock Chart & Stats
AU$0.02
<AU$0.01(8.70%)
At close: 4:00 PM EDT
AU$0.02
<AU$0.01(8.70%)
Day’s Range― - ―
52-Week RangeAU$0.02 - AU$0.04
Previous CloseN/A
Volume2.21M
Average Volume (3M)0.00
Market Cap
AU$9.73M
Enterprise ValueAU$22.62
Total Cash (Recent Filing)AU$242.86K
Total Debt (Recent Filing)AU$10.35M
Price to Earnings (P/E)―
Beta-0.25
Next Earnings
Sep 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding389,104,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.16
Price to Book (P/B)6.55
Price to Sales (P/S)1.33
P/FCF Ratio-3.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue RecoveryA ~53% revenue rebound in 2025 indicates renewed demand or successful commercial activity. Durable top-line growth provides the base to absorb fixed costs, supports scaling of production and R&D, and improves the odds of reaching sustainable profitability if the trend persists.
Positive Gross Profit In 2025Recording positive gross profit shows the core product economics cover direct costs, a necessary condition for longer-term profitability. If SG&A and overhead are controlled, operational leverage from higher volumes can convert gross profit into operating profit over the medium term.
Sizable Asset Base Provides OptionalityA sizable asset base gives the company collateral and operational capacity to continue manufacturing, secure financing or pursue partnerships. That structural resource can enable strategic transactions or secured funding to bridge to profitability if managed carefully.
Bears Say
Persistent Negative Cash FlowConsistent negative operating and free cash flow means the business is cash consuming rather than self-sustaining. This creates ongoing reliance on external financing, heightens dilution or refinancing risk, and constrains investment and strategic flexibility until cash flow turns positive.
Material Increase In LeverageA jump to ~4.7x debt/equity sharply reduces financial resilience. Higher fixed obligations raise default and refinancing risk, increase interest burden on future profits, and limit the company's ability to fund growth or absorb shocks without further dilutive or costly capital raises.
Ongoing Meaningful Net LossesSustained net losses and negative ROE mean the business has not achieved profitable unit economics. Even with revenue recovery, margins remain structurally negative, eroding equity and requiring either persistent external funding or fundamental operational changes to restore long-term viability.
Epsilon Healthcare Limited News
EPN FAQ
What was Epsilon Healthcare Limited’s price range in the past 12 months?
Epsilon Healthcare Limited lowest share price was AU$0.02 and its highest was AU$0.04 in the past 12 months.
What is Epsilon Healthcare Limited’s market cap?
Epsilon Healthcare Limited’s market cap is AU$9.73M.
When is Epsilon Healthcare Limited’s upcoming earnings report date?
Epsilon Healthcare Limited’s upcoming earnings report date is Sep 02, 2026 which is in 30 days.
How were Epsilon Healthcare Limited’s earnings last quarter?
Epsilon Healthcare Limited released its earnings results on Feb 27, 2026. The company reported AU$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Epsilon Healthcare Limited overvalued?
According to Wall Street analysts Epsilon Healthcare Limited’s price is currently Overvalued.
Does Epsilon Healthcare Limited pay dividends?
Epsilon Healthcare Limited does not currently pay dividends.
What is Epsilon Healthcare Limited’s EPS estimate?
Epsilon Healthcare Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Epsilon Healthcare Limited have?
Epsilon Healthcare Limited has 389,104,000 shares outstanding.
What happened to Epsilon Healthcare Limited’s price movement after its last earnings report?
Epsilon Healthcare Limited reported an EPS of AU$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Epsilon Healthcare Limited?
Currently, no hedge funds are holding shares in AU:EPN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Epsilon Healthcare Limited Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Insider Transactions
Bought Shares
Worth $29.6K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
84.04%
Trailing 12-Months
Company Description
Epsilon Healthcare Limited
Epsilon Healthcare Limited operates as an Australian-based healthcare and pharmaceutical firm, with significant operations also extending into Canada. Established in 2016 and headquartered in Sydney, the company specializes in several areas: manufacturing and distributing a range of hydroponic supplies, including equipment, materials, and vital nutrients; developing and providing medicinal cannabis products; and offering comprehensive, ready-to-implement solutions for cannabis cultivation. The company officially rebranded from THC Global Group Limited to Epsilon Healthcare Limited in February 2021.
Technical Analysis
Vita Life Sciences Limited
―
Little Green Pharma Ltd.
―
Medical Developments International Limited
―
Althea Group Holdings Ltd.
―
IDT Australia Limited
―